Novartis Becomes The First To Link Sustainability Bond To A ‘Social Goal’
Novartis’ bond sale raises “1.85 billion” euro to expand malaria and leprosy treatment.
Novartis’ bond sale raises “1.85 billion” euro to expand malaria and leprosy treatment.
Study looks beyond cost benefits and delved deeper in the health benefit of switching to renewable energy.